Page last updated: 2024-11-07

dehydroepiandrosterone and Dementia, Vascular

dehydroepiandrosterone has been researched along with Dementia, Vascular in 6 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Dementia, Vascular: An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)

Research Excerpts

ExcerptRelevanceReference
"A neurodegenerative disease such as Alzheimer's disease (AD) is associated with significantly higher dehydroepiandrosterone (DHEA) levels in cerebrospinal fluid (CSF)."1.32Neurosteroids: Cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics. ( Hampl, R; Hill, M; Jo, DH; Kim, SB; Kwak, YT; Morfin, R, 2003)
"The early differential diagnosis of Alzheimer's disease (AD) remains still problematic."1.32Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia. ( Bicíková, M; Hampl, R; Havlíková, H; Hill, M; Jirák, R; Rípová, D; Tallová, J, 2004)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakr, HF1
Khalil, KI1
Hussein, AM1
Zaki, MS1
Eid, RA1
Alkhateeb, M1
Kim, SB1
Hill, M2
Kwak, YT1
Hampl, R2
Jo, DH1
Morfin, R1
Bicíková, M1
Rípová, D1
Jirák, R1
Havlíková, H1
Tallová, J1
Solerte, SB1
Ferrari, E2
Cuzzoni, G1
Locatelli, E1
Giustina, A1
Zamboni, M1
Schifino, N1
Rondanelli, M1
Gazzaruso, C1
Fioravanti, M1
Magri, F1
Cravello, L1
Barili, L1
Sarra, S1
Cinchetti, W1
Salmoiraghi, F1
Micale, G1
Bernardi, F1
Lanzone, A1
Cento, RM1
Spada, RS1
Pezzani, I1
Genazzani, AD1
Luisi, S1
Luisi, M1
Petraglia, F1
Genazzani, AR1

Reviews

1 review available for dehydroepiandrosterone and Dementia, Vascular

ArticleYear
Stress and dementia: the role of the hypothalamicpituitary-adrenal axis.
    Aging clinical and experimental research, 2006, Volume: 18, Issue:2

    Topics: Adult; Aged; Aging; Alzheimer Disease; Case-Control Studies; Circadian Rhythm; Cognition Disorders;

2006

Other Studies

5 other studies available for dehydroepiandrosterone and Dementia, Vascular

ArticleYear
Effect of dehydroepiandrosterone (DHEA) on memory and brain derived neurotrophic factor (BDNF) in a rat model of vascular dementia.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2014, Volume: 65, Issue:1

    Topics: Acetylcholine; Animals; Brain-Derived Neurotrophic Factor; Carotid Artery, Common; Dehydroepiandrost

2014
Neurosteroids: Cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:11

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Chromatography, High Pressure Liquid; Dehydroepiandroste

2003
Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia.
    Clinical chemistry and laboratory medicine, 2004, Volume: 42, Issue:5

    Topics: 17-alpha-Hydroxypregnenolone; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Chromatography

2004
Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate.
    Dementia and geriatric cognitive disorders, 2005, Volume: 19, Issue:1

    Topics: Adult; Age Factors; Aged; Alzheimer Disease; Amyloid beta-Peptides; Angiogenic Proteins; Brain; Cell

2005
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia.
    European journal of endocrinology, 2000, Volume: 142, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Case-Control Studies; Corticotropin-Re

2000